Community-acquired pneumonia. Cost-effective antimicrobial therapy
1Infectious Disease Division, Winthrop-University Hospital, Mineola, New York, USA.
Postgraduate Medicine
|January 1, 1996
Summary
Three antibiotics, including doxycycline, ofloxacin, and azithromycin, offer effective monotherapy for community-acquired pneumonias. Oral administration provides cost savings and facilitates earlier patient discharge.
Area of Science:
- Infectious Diseases
- Pharmacology
- Pulmonology
Background:
- Community-acquired pneumonia (CAP) requires effective treatment options.
- Traditional CAP therapy often involves lengthy intravenous administration.
- Economic factors are increasingly influencing treatment strategies.
Purpose of the Study:
- To evaluate the efficacy of specific oral antibiotics for community-acquired pneumonia.
- To highlight the benefits of intravenous-to-oral switch therapy.
- To discuss the role of oral antibiotics in cost-effective patient management.
Main Methods:
- Review of current therapeutic guidelines for CAP.
- Analysis of antibiotic bioavailability (intravenous vs. oral).
- Assessment of treatment outcomes for oral monotherapy.
Main Results:
- Doxycycline, ofloxacin, and azithromycin are effective for typical and atypical CAP.
- These antibiotics allow for monotherapy and intravenous-to-oral switch.
- Oral administration demonstrates equivalent bioavailability and efficacy to intravenous routes.
- Oral therapy can lead to significant cost savings and earlier patient discharge.
Conclusions:
- Doxycycline, ofloxacin, and azithromycin represent optimal oral therapy for CAP.
- Intravenous-to-oral switch therapy is a cost-effective strategy.
- Oral antibiotic regimens can safely and effectively treat moderately to severely ill CAP patients.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...